Traded Dec 11, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 12, 2025 · Filed Nov 14, 2025
A Vicor director sold $115K of Vicor shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$115,104
Shares × reported transaction price
22 days after results of Oct 21, 2025, 99 days before results of Feb 19, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −5.2% | −1.9% | −3.3% |
| 30 days | +7.4% | +1.3% | +6.1% |
| 90 days | +84.6% | +1.4% | +83.2% |
| 180 days | +247.5% | +10.5% | +237.0% |
Past results only. Not a forecast.
Traded Dec 11, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Dec 11, 2025 · filed 2 days laterNot under a reported trading plan
A Vicor director sold $266K of Vicor shares. The filing does not indicate a pre-arranged trading plan.
Traded Dec 11, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.